Finance

Lists
Why is 524669 up 2,30%?
Dive Deeper
524669:BOM
Hester Biosciences Ltd
2 240,00 INR
+2,30%
(+50,40) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524669...
Open
2 206,70 INR
High
2 240,00 INR
Low
2 206,70 INR
Mkt. cap
19,02 მლრდ.
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 INR
Ex-dividend date
14 ივლ. 2026
P/E ratio
14,12
52-wk high
2 669,00 INR
52-wk low
1 250,95 INR
EPS
158,68 INR
Shares outstanding
8,51 მლნ.
No. of employees
483
Open
2 206,70 INR
High
2 240,00 INR
Low
2 206,70 INR
Mkt. cap
19,02 მლრდ.
Avg. vol.
373,00
Volume
69,00
Dividend
0,49%
Quarterly dividend
2,75 INR
Ex-dividend date
14 ივლ. 2026
P/E ratio
14,12
52-wk high
2 669,00 INR
52-wk low
1 250,95 INR
EPS
158,68 INR
Shares outstanding
8,51 მლნ.
No. of employees
483
News stories
From web sources and news partners
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
Sector-
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
709,69 მლნ.
774,15 მლნ.
1,02 მლრდ.
772,44 მლნ.
Cost of goods sold
193,19 მლნ.
207,28 მლნ.
251,52 მლნ.
170,79 მლნ.
Cost of revenue
193,19 მლნ.
207,28 მლნ.
251,52 მლნ.
170,79 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155,01 მლნ.
155,18 მლნ.
264,13 მლნ.
148,84 მლნ.
Operating expense
442,86 მლნ.
433,25 მლნ.
465,39 მლნ.
444,32 მლნ.
Total operating expenses
636,05 მლნ.
640,53 მლნ.
716,91 მლნ.
615,11 მლნ.
Operating income
73,64 მლნ.
133,62 მლნ.
299,41 მლნ.
157,33 მლნ.
Other non operating income
97,27 მლნ.
6,69 მლნ.
-133,21 მლნ.
16,43 მლნ.
EBT including unusual items
170,36 მლნ.
135,24 მლნ.
250,89 მლნ.
1,02 მლრდ.
EBT excluding unusual items
170,36 მლნ.
135,24 მლნ.
203,96 მლნ.
163,33 მლნ.
Income tax expense
27,05 მლნ.
42,14 მლნ.
85,42 მლნ.
49,50 მლნ.
Effective tax rate
15,88%
31,16%
34,05%
4,87%
Other operating expenses
244,31 მლნ.
233,76 მლნ.
58,89 მლნ.
225,04 მლნ.
Net income
144,49 მლნ.
87,65 მლნ.
159,83 მლნ.
969,81 მლნ.
Net profit margin
20,36%
11,32%
15,73%
125,55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
15,79 მლნ.
-
Interest expense
-22,07 მლნ.
-18,22 მლნ.
-15,77 მლნ.
-30,80 მლნ.
Net interest expenses
-22,07 მლნ.
-18,22 მლნ.
20,00 ათ.
-30,80 მლნ.
Depreciation and amortization charges
43,54 მლნ.
44,31 მლნ.
59,14 მლნ.
70,44 მლნ.
EBITDA
116,32 მლნ.
174,66 მლნ.
330,34 მლნ.
188,26 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები